Intussusception Market Report 2026

The intussusception market size has grown steadily in recent years. It will grow from $4.67 billion in 2025 to $4.85 billion in 2026 at a compound annual growth rate (CAGR) of 4%. The growth in the historic period can be attributed to high incidence of pediatric gastrointestinal emergencies, widespread use of barium enema for diagnosis and treatment, established surgical intervention protocols, increasing availability of hospital emergency services, growing awareness of childhood abdominal disorders.

The intussusception market size is expected to see steady growth in the next few years. It will grow to $5.68 billion in 2030 at a compound annual growth rate (CAGR) of 4%. The growth in the forecast period can be attributed to advancements in diagnostic imaging technologies, increasing emphasis on early and non-invasive treatment approaches, expansion of pediatric emergency care infrastructure, growing training programs for gastrointestinal emergencies, rising healthcare access in developing regions. Major trends in the forecast period include increasing use of ultrasound as first-line diagnostic tool, growing preference for non-surgical enema reduction procedures, rising focus on early diagnosis in pediatric emergency care, increasing adoption of minimally invasive surgical techniques, growing awareness and training for rapid intussusception management.

The increasing prevalence of intestinal disorders is expected to drive the growth of the intussusception market in the coming years. An intestinal disorder refers to any medical condition or health issue that disrupts the normal functioning of the intestines, which are components of the digestive system responsible for nutrient absorption and waste elimination from the body. A growing occurrence of intestinal disorders such as inflammatory bowel disease and gastrointestinal cancers can result in earlier diagnosis, better treatment options, and improved support for intussusception patients, ultimately enhancing their health and well-being. For example, in January 2024, the Colorectal Cancer Alliance, a US-based nonprofit patient advocacy and research organization, reported that an estimated 152,810 new colorectal cancer cases are expected in 2024, including 106,590 colon cancer cases and 46,220 rectal cancer cases. The Alliance also projects approximately 53,010 deaths from colorectal cancer in 2024, reflecting a slight increase from the previous year’s estimate of 52,550 deaths. Therefore, the rising prevalence of intestinal disorders is expected to propel the growth of the intussusception market.

The rising healthcare expenditure is contributing to the growth of the intussusception market. Healthcare expenditure refers to the total financial resources dedicated to the healthcare sector within a particular region, country, or organization. It involves the distribution of funds to meet medical needs, and the occurrence of conditions like intussusception increases spending by requiring medical interventions, diagnostic procedures, and possible surgical treatments, thereby affecting overall healthcare costs. For example, in November 2023, according to the Canadian Institute for Health Information, a Canada-based health institute, total health spending in Canada is projected to reach $344 billion in 2023, equivalent to $8,740 per person. This represents a 2.8% increase compared to the previous year, which recorded only a 1.5% growth in health spending in 2022, reflecting a significant rebound in healthcare investment. Thus, the increase in healthcare spending is driving the growth of the intussusception market.

The increasing implementation of pediatric vaccination programs is expected to drive the growth of the intussusception market in the coming years. Pediatric vaccination programs are structured public-health initiatives that provide routine immunizations to infants and young children to prevent infectious diseases. The expansion of pediatric vaccination programs is fueled by government-led immunization efforts, as broader public vaccination campaigns enhance vaccine accessibility and increase routine immunization coverage among infants and young children. These programs facilitate the early detection, clinical management, and post-vaccination monitoring of rare bowel complications such as intussusception linked to rotavirus vaccination, thereby reinforcing overall vaccine safety and public trust. For example, in May 2025, according to the UK Health Security Agency, a UK-based government organization, during the 2023-2024 season, a school-based program targeting all children aged 4 to 16 years (Reception to Year 11) in England achieved a coverage of 52.2% among eligible children in Reception to Year 9 (3,498,576 out of 6,708,016). This was slightly higher than the 51.9% coverage (3,502,566 out of 6,747,523) reported in the 2022-2023 season. Hence, the growth of pediatric vaccination programs is driving the expansion of the intussusception market.

Major companies operating in the intussusception market are Abbott Laboratories, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, GE HealthCare Technologies Inc., Steris Plc, Cook Medical LLC, Shimadzu Corporation, Carestream Health, CONMED Corporation, EndoChoice Holdings Inc., Fujifilm Healthcare Solutions, Richard Wolf GmbH, Karl Storz SE And Co. KG.

North America was the largest region in the intussusception market in 2025. The regions covered in the intussusception market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the intussusception market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have impacted the intussusception market by increasing costs associated with imported diagnostic imaging equipment, contrast agents, and surgical instruments. These effects are most notable in hospitals and clinics, particularly in regions reliant on imported medical devices such as north america and asia pacific. Higher tariffs have led to increased procedural and equipment costs. However, they have also encouraged local manufacturing, procurement diversification, and investment in cost-efficient diagnostic technologies, supporting long-term market sustainability.

The intussusception market research report is one of a series of new reports that provides intussusception market statistics, including intussusception industry global market size, regional shares, competitors with a intussusception market share, detailed intussusception market segments, market trends and opportunities, and any further data you may need to thrive in the intussusception industry. This intussusception market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Intussusception is a medical condition in which a segment of the intestine folds into an adjacent section, obstructing the passage of food, fluids, and gas through the affected area, resulting in symptoms such as severe abdominal pain, vomiting, and bloody stools. Diagnosis is typically made based on symptoms, physical examination, and imaging studies.

The primary types of intussusception are idiopathic and secondary intussusception. Idiopathic intussusception occurs when one segment of the intestine telescopes into another, causing an obstruction that can often be treated non-surgically using pneumatic or hydrostatic reduction. Treatment options include enema reduction, surgery, and other approaches, with diagnosis made through methods such as barium enema, ultrasound, and X-ray. These services are provided by hospitals, clinics, and other healthcare facilities.

The intussusception market consists of revenues earned by entities that provide diagnostic services such as clinical examination, magnetic resonance imaging, exploratory laparoscopy, or laparotomy that help in diagnosing and managing intussusception as a medical condition. The market value includes the value of related goods sold by the service provider or included within the service offering. The intussusception market also includes sales of drugs such as acetaminophen with codeine and ibuprofen. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.